NAGE · Niagen Bioscience, Inc. · Exempt Offerings
Market Cap
$242.01M
Shares
79.13M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1386570
CUSIP
171077407
13F (30d)
88 filings
88 filers
Visit website
Investor relations